Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Leukaemia Foundation joins forces with blood cancer survivor Briony Benjamin to raise awareness of lymphoma

Leukaemia Foundation 3 mins read

On World Lymphoma Awareness Day (September 15), the Leukaemia Foundation is joining forces with Gold Coast author, content creator, motivational speaker and inspiring lymphoma survivor, Briony Benjamin.   

As a national ambassador for the Leukaemia Foundation, Briony is hoping to raise much-needed awareness of lymphoma - the most diagnosed form of blood cancer in Australia – and is encouraging anyone impacted by the disease to reach out to the Leukaemia Foundation for support.   

With over 65,200 Australians currently living with lymphomai, World Lymphoma Awareness Day provides an opportunity for the Leukaemia Foundation to educate people on the signs and symptoms of the disease, which can often be subtle and difficult to recognise.  

Common lymphoma symptoms include painless lumps around the lymph nodes usually in the neck, armpit or groin that may be dismissed as harmless. Other symptoms are night sweats, recurrent infections or fevers, and even itchy skin. 

As someone who was misdiagnosed several times before eventually being told she had lymphoma, Briony believes that because the disease can be difficult to spot, it’s especially important to listen to your body and to act when something doesn’t feel right. 

The Leukaemia Foundation encourages Australians to speak to your GP if you have ongoing symptoms that can’t be explained. The sooner that a blood cancer diagnosis occurs, the greater chance people have of beating the disease. 

Anyone impacted by lymphoma, or any type of blood cancer can contact Australia’s blood cancer support line Monday to Friday via calling 1800 620 420 or visit bloodcancer.org.au.   

AVAILABLE FOR INTERVIEW - BRIONY BENJAMIN: 

  • Briony is a Gold Coast based storyteller, content creator, motivational speaker and author of the book and journal ‘Life is Tough But So Are You’.  

  • Briony was a healthy and fit 31-year-old before she was diagnosed with stage four Hodgkin lymphoma in 2018, a shock diagnosis which instantly turned her life upside down. 

  • Briony was thrown into life-saving treatment almost immediately including months of grueling chemotherapy where she lost her hair. 

  • After eventually being declared cancer-free, it took Briony a long time to recover physically and emotionally from her blood cancer experience.  

  • She is now a healthy and thriving blood cancer survivor and is pregnant with her first child due in October. 

  • Briony is available for interviews to speak about her own first-hand experience with lymphoma and what she hopes to achieve in collaboration with Leukaemia Foundation on World Lymphoma Awareness Day.  

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at media@leukaemia.org.au. 

Lymphoma – facts and figuresii: 

  • Lymphoma is the most common type of blood cancer in Australia. 

  • In 2023, 7,403 Australians will be diagnosed with lymphoma. This is projected to more than double to reach 17,171 people per year by 2035.  

  • Currently, 65,233 Australians are living with lymphoma.  

 


About us:

About the Leukaemia Foundation: The Leukaemia Foundation has been named Australia's most reputable cancer charity and third most reputable charity overall. We stand with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn to, fighting to get them access to the best care. We also accelerate research that is delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at leukaemia.org.au 


Contact details:

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at media@leukaemia.org.au. 

Media

More from this category

  • CharitiesAidWelfare, Foreign Affairs Trade
  • 14/09/2024
  • 06:00
Plan International Australia

Media Release: Hundreds of people dead and more than half a million displaced as Vietnam pummelled by Typhoon Yagi

Friday 13 September: For immediate release Press release Hundreds of people dead and more than half a million displaced as Vietnam pummelled by Typhoon Yagi Severe, widespread flooding and landslides in northern Vietnam has left swathes of rural villages submerged in water and more than half a million families and children in need of humanitarian assistance. HANOI, VIETNAM — More than 300 people in northern Vietnam have been reported dead or missing in the wake of Typhoon Yagi – the most severe storm to have hit Southeast Asia this year and the worst to have struck Vietnam in 30 years.…

  • CharitiesAidWelfare, Sport Recreation
  • 13/09/2024
  • 16:59
Heart Foundation

ALERT: Lewis runs first Sydney Marathon in honour of late Dad

Friday, 13 September, 2024 Lewis runs first Sydney Marathon to raise money for heart research Lewis Reeder to run in memory of his late father who died suddenly from heart disease last year Bondi Junction resident Lewis Reeder, 31, is running his first marathon this Sunday at the Sydney Marathon to raise funds for the Heart Foundation in memory of his 59-year-old father, Karl, who passed away from sudden heart failure during a bike ride in England on 7 September 2023. Inspired to honour his father, Lewis decided now was the time to tackle a marathon. Along with seven friends,…

  • Medical Health Aged Care
  • 13/09/2024
  • 12:40
Zenas BioPharma

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.